{"id":554205,"date":"2026-07-22T15:08:10","date_gmt":"2026-07-22T15:08:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/554205\/"},"modified":"2026-07-22T15:08:10","modified_gmt":"2026-07-22T15:08:10","slug":"safety-in-percutaneous-liver-ablation","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/554205\/","title":{"rendered":"Safety in Percutaneous Liver Ablation"},"content":{"rendered":"<p>        <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/07\/liver-concept.jpg\" class=\"img-fluid\" alt=\"Illustration of the upper abdomen showing the liver highlighted in orange within a transparent view of the torso.\"\/><\/p>\n<p>    Safety and an Evolving Role in Treatment<\/p>\n<p>Dr. Doppelt believes the team\u2019s findings give radiologists and multidisciplinary teams a strong, contemporary safety reference when discussing curative therapy for small malignant liver neoplasms.<\/p>\n<p>\u201cFor patients, the message is important: In modern practice, percutaneous thermal ablation is a minimally invasive treatment with a very low risk of major complications and extremely low procedure-related mortality,\u201d he said.<\/p>\n<p>Still, questions remain about how ablation fits into the broader treatment landscape. Evidence from prospective randomized trials on colorectal metastases and hepatocellular carcinoma suggests that thermal ablation can achieve outcomes comparable to surgery in select patients, particularly for small lesions. Michael A. Bettmann, MD, professor of radiology emeritus at Wake Forest University School of Medicine in Winston-Salem, NC, said the curative ability of the treatment remains unclear. <\/p>\n<p>In a related editorial, Dr. Bettmann stated that surgery is the only therapeutic approach to hepatocellular carcinoma that may be considered curative. He added that the prognosis for both primary and metastatic liver cancer is poor overall, and that even surgery that involves resection or transplant yields a five-year survival rate of less than 50%.<\/p>\n<p>\u201cThermal ablation is most logical, theoretically, for use with a limited number of lesions\u00a0that originate in the target\u00a0organ\u2014in this case, the liver,\u201d Dr. Bettmann explained. \u201cIf lesions are metastatic, ablation can be combined\u00a0with other treatments, such as systemic medication.\u201d<\/p>\n<p>Further Clinical Trials Needed to Determine Best Use<\/p>\n<p>Dr. Bettmann said that future research will almost certainly include\u00a0a comparison of different\u00a0methods: radiofrequency ablation, cryoablation, microwave ablation and US ablation. <\/p>\n<p>\u201cAll have shown considerable efficacy, but there are so many variables that it is very hard to reach firm conclusions,\u201d Dr. Bettman said. \u201cFurther, ablation is rarely used alone. Determining how to best use it in conjunction with radiation, arterial embolization techniques or\u2014most importantly\u2014targeted systemic therapy will be the major focus of clinical research.\u201d<\/p>\n<p>Dr. Doppelt agrees that future clinical trials need to examine how radiologists can combine ablation with systemic therapies such as immunotherapy.<\/p>\n<p>\u201cIf we know the baseline safety profile of ablation itself, it becomes much easier to interpret adverse events in combination studies and to design future trials more rigorously,\u201d he concluded.<\/p>\n<p>For More Information<\/p>\n<p>Access the Radiology study, \u201c<a href=\"https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.251517\" rel=\"nofollow noopener\" target=\"_blank\">The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years<\/a>,\u201d and the related editorial, \u201c<a href=\"https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.260546\" rel=\"nofollow noopener\" target=\"_blank\">Ablation of Liver Malignancies Is Safe: Does This Fully Define Its Role?<\/a>\u201d<\/p>\n<p>Read previous RSNA News articles on thermal ablation:<\/p>\n","protected":false},"excerpt":{"rendered":"Safety and an Evolving Role in Treatment Dr. Doppelt believes the team\u2019s findings give radiologists and multidisciplinary teams&hellip;\n","protected":false},"author":2,"featured_media":554206,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[85,46,125],"class_list":["post-554205","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-il","tag-israel","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/554205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=554205"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/554205\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/554206"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=554205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=554205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=554205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}